Par Pharmaceutical Companies, Inc.  

(Public, NYSE:PRX)   Watch this stock  
Find more results for PAR PHARMACEUTICAL, INC.�

Officers and directors

Paul V. Campanelli
Chief Executive Officer, Director
Michael A. Tropiano
Chief Financial Officer, Executive Vice President, Director
Terrance John Coughlin
Chief Operating Officer
Thomas J. Haughey
Chief Administrative Officer, General Counsel, Director


1 Ram Ridge Rd
United States - Map
+1-845-5735500 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Par Pharmaceutical Companies, Inc. is a United States-based holding company. The Company, through its wholly owned subsidiary, Par Pharmaceutical, Inc., is engaged in developing, licensing, manufacturing, marketing and distributing generic drugs in the United States. The Company has a generics portfolio of approximately 95 products across a range of dosage forms and delivery systems, which include immediate and extended release oral solids, consisting of tablets, orally disintegrating tablets, capsules and powders; injectables; nasal sprays; ophthalmics, and transdermal patches. The Company has two segments: Par Pharmaceutical, which includes generic products marketed under Par Pharmaceutical and sterile products, marketed under Par Sterile Products, LLC, and Par Specialty Pharmaceuticals, which markets and distributes two branded prescription products, Nascobal (cyanocobalamin, USP) Nasal Spray and Megace ES.

Related companies

* Delayed by up to 20 minutes -  Disclaimer